Holen Sie sich die Stockscreener-App
0.00
100.00%
-115.07
Handel nachbörslich:
115.11
115.11
+
Arcellx Inc Aktie (ACLX) Neueste Nachrichten
Gilead’s HIV Priority Review And Arcellx Deal Refocus Long‑Term Story - Yahoo Finance
Arcellx, Inc. Financial Disclosures & Filings - TradingView
Pictet Asset Management Holding SA Decreases Stake in Arcellx, Inc. $ACLX - MarketBeat
Gilead buys Arcellx (ACLX) for $115 per share plus $5 CVR - Stock Titan
MSN Money - MSN
Arcellx (ACLX) to Release Earnings on Thursday - MarketBeat
Arcellx's (ACLX) "Neutral" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Are medical stocks lagging Arcellx (ACLX) this year? - MSN
Arcellx (NASDAQ:ACLX) Sets New 12-Month HighTime to Buy? - MarketBeat
Gilead Sciences (GILD) Closes $7.8B Arcellx Buyout — What Investors Need to Know - MEXC
Arcellx (ACLX) director-linked fund exits as Gilead buyout closes - Stock Titan
Arcellx Acquired in Cash-and-CVR Deal, Going Private - TipRanks
Arcellx (NASDAQ: ACLX) director cashes out in Gilead merger deal - Stock Titan
Gilead deal cashes out Arcellx (NASDAQ: ACLX) director options - Stock Titan
[Form 4] Arcellx, Inc. Insider Trading Activity - Stock Titan
Arcellx (ACLX) director cancels stock options for cash and CVRs in Gilead merger - Stock Titan
Arcellx (ACLX) director’s shares and options cashed out in Gilead deal - Stock Titan
Arcellx (ACLX) CFO logs tender-offer share disposal and equity award conversions in Gilead merger - Stock Titan
Arcellx (ACLX) CMO reshapes stock and options in Gilead deal - Stock Titan
Arcellx (ACLX) equity cashed out at $115 plus CVRs in Gilead deal - Stock Titan
Gilead completes Arcellx merger; Arcellx (NASDAQ: ACLX) deregisters S-3 - Stock Titan
Gilead buys Arcellx (ACLX) for $115 cash plus CVR; holder at 0% - Stock Titan
Gilead buys Arcellx (NASDAQ: ACLX) in $7.1B cash and CVR deal - Stock Titan
Gilead Sciences (GILD) Stock Lands $7.8B Arcellx Deal — Is This the Buy Opportunity? - MEXC Exchange
Gilead completes $7.8 billion acquisition of Arcellx By Investing.com - Investing.com India
Gilead Sciences, Inc. completed the acquisition of 77.2% stake in Arcellx, Inc. from New Enterprise Associates, Inc., Sr One Capital Fund I Aggregator, LP, fund managed by SR One Capital Management, LP, and others. - marketscreener.com
Gilead Sciences (GILD) Completes Acquisition of Arcellx, Inc. - GuruFocus
Gilead Sciences completes acquisition of Arcellx ahead of potential commercial launch of Anito-cel - marketscreener.com
Gilead Completes $7.8 Billion Acquisition of Arcellx - Contract Pharma
Gilead Sciences Finalizes $7.8 Billion Acquisition of Arcellx - marketscreener.com
Recent Arcellx deal leaves Gilead Sciences stock consolidating amid persistent oversold signals - Traders Union
Gilead Sciences Completes $7.8 Billion Acquisition of Arcellx, Securing Full Control of CAR T Therapy Anito-cel - citybiz
Gilead Sciences Completes $7.8 Billion Acquisition of Arcellx to Accelerate Launch of Anito-cel CAR T Therapy for Multiple Myeloma 1 - Minichart
Arcellx (NASDAQ: ACLX) files to withdraw Nasdaq listing - Stock Titan
Gilead Sciences Completes Acquisition of Arcellx and Anito-cel - TipRanks
Gilead fully acquires Arcellx (NASDAQ: ACLX) as tender offer and merger close - Stock Titan
Arcellx (ACLX) to Merge with Gilead Unit for $115/Share plus CVR - Stock Titan
Gilead completes $7.8 billion acquisition of Arcellx - Investing.com
Gilead (NASDAQ: GILD) closes Arcellx deal, gains full control of anito-cel - Stock Titan
Gilead Sciences (ACLX) to close merger; 77.2% tendered, $115 cash plus CVR - Stock Titan
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel - Business Wire
Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN
Arcellx (NASDAQ:ACLX) Upgraded to Strong-Buy at Truist Financial - MarketBeat
Citigroup downgrades Arcellx (ACLX) - MSN
Arcellx, Inc.(NasdaqGS: ACLX) dropped from S&P TMI Index - marketscreener.com
Arcellx, Inc.(NasdaqGS: ACLX) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Arcellx, Inc.(NasdaqGS: ACLX) dropped from S&P Global BMI Index - marketscreener.com
Arcellx sinks following results from Kelonia CAR-T therapy for multiple myeloma - MSN
Are Medical Stocks Lagging Arcellx (ACLX) This Year? - Yahoo Finance
Gilead Sciences Obtains Regulatory Approval for Arcellx Acquisition - HarianBasis.co
ACLX Stock Price, Quote & Chart | ARCELLX INC (NASDAQ:ACLX) - ChartMill
Gilead Sciences (GILD) Set to Acquire Arcellx - Insider Monkey
Gilead extends Arcellx tender offer again - MSN
Arcellx, Inc.(NasdaqGS: ACLX) dropped from Russell 2500 Growth-Dynamic Index - marketscreener.com
M&A snapshot: Gilead acquires Arcellx for $7.8B - MSN
Why did ACLX stock surge 80% in pre-market today? - MSN
Gilead extends Arcellx tender offer expiration date - MSN
2.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):